LOMUSTINE, IFOSFAMIDE, BLEOMYCIN, VINCRISTINE AND CISPLATIN (CIBO-P) IS AN EFFECTIVE REGIMEN FOR PATIENTS WITH POOR PROGNOSTIC REFRACTORY OR MULTIPLY RELAPSED AGGRESSIVE NON-HODGKIN'S LYMPHOMA

ANNALS OF ONCOLOGY(2004)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要